Clinical Trials
70 trialsDP-04
AstraZeneca
DESCENT-1
A2 Biotherapeutics Inc.
LEARN
University of Sydney
OvAR-Y
Washington University School of Medicine
SHERLOCK
University Health Network, Toronto
ELEPHAS-02
Elephas
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
FL-261 Imaging for Cancer Diagnosis and Staging
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
MOMENTUM
UMC Utrecht
QVA-Mod
Hospices Civils de Lyon
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
ELEPHAS-05
Elephas
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
University of Colorado, Denver
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
University of California, San Francisco
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
Kansas State University
PREMIER
RefleXion Medical
DELFI-L101
Delfi Diagnostics Inc.
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Nanjing First Hospital, Nanjing Medical University
PREFER
Labcorp Corporation of America Holdings, Inc
MOM
Inova Health Care Services
FUTURE
Assistance Publique Hopitaux De Marseille
MOHCCN-O
University Health Network, Toronto
Improving Evidence-Based Care for Cancer Patients
Medical University of South Carolina
Optimization of MRI for Radiation Therapy
University of Michigan Rogel Cancer Center
ROOT
Taproot Health
OCTANE
University Health Network, Toronto
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Radiogenomics in Aerodigestive Tract Cancers
Buddhist Tzu Chi General Hospital
POSITive
European Institute of Oncology
MORRIS
Umeå University
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
Sunnybrook Health Sciences Centre
ART-02
Charite University, Berlin, Germany
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy
Samsung Medical Center
WiZen
Technische Universität Dresden
DETECT
Boryung Pharmaceutical Co., Ltd
PIONEER
SpeciCare
SurgiCovid
Hospices Civils de Lyon
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
INFORM
University of Alberta
N1
CureOne